- Report
- May 2025
- 150 Pages
Global
From €5232EUR$5,950USD£4,561GBP
- Report
- October 2025
- 184 Pages
Global
From €3118EUR$3,545USD£2,718GBP
€3464EUR$3,939USD£3,019GBP
- Report
- September 2025
- 250 Pages
Global
From €3949EUR$4,490USD£3,442GBP
- Report
- December 2025
- 354 Pages
Global
From €5145EUR$5,850USD£4,484GBP
- Report
- June 2025
- 185 Pages
Global
From €3957EUR$4,500USD£3,450GBP
- Report
- June 2025
- 81 Pages
Global
From €3500EUR$4,263USD£3,158GBP
- Report
- October 2025
- 87 Pages
United States
From €4265EUR$4,850USD£3,718GBP
- Report
- November 2025
- 150 Pages
Global
From €5232EUR$5,950USD£4,561GBP
- Report
- November 2025
- 180 Pages
Global
From €3118EUR$3,545USD£2,718GBP
€3464EUR$3,939USD£3,019GBP
- Report
- October 2025
- 189 Pages
Global
From €3118EUR$3,545USD£2,718GBP
€3464EUR$3,939USD£3,019GBP
- Report
- August 2025
- 199 Pages
Global
From €3118EUR$3,545USD£2,718GBP
€3464EUR$3,939USD£3,019GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €879EUR$1,000USD£767GBP
€1099EUR$1,250USD£958GBP
- Report
- December 2025
- 187 Pages
Global
From €5145EUR$5,850USD£4,484GBP
- Report
- November 2025
- 150 Pages
Global
From €3386EUR$3,850USD£2,951GBP
- Report
- June 2025
- 150 Pages
Global
From €2374EUR$2,699USD£2,069GBP
- Report
- February 2024
- 126 Pages
Global
From €1972EUR$2,243USD£1,719GBP
€2629EUR$2,990USD£2,292GBP
- Report
- May 2024
- 129 Pages
Global
From €4858EUR$5,524USD£4,235GBP
€5715EUR$6,499USD£4,982GBP
- Report
- April 2023
- 110 Pages
Global
From €4177EUR$4,750USD£3,641GBP

The Intravenous Iron market is a segment of the Hematological Drugs market, which includes drugs used to treat anemia and other blood disorders. Intravenous Iron is a type of drug used to treat iron deficiency anemia, a condition in which the body does not have enough iron to produce healthy red blood cells. Intravenous Iron is administered directly into the bloodstream, allowing for a more rapid increase in iron levels than oral iron supplements.
Intravenous Iron is used in a variety of settings, including hospitals, clinics, and home care. It is often prescribed to patients who are unable to take oral iron supplements due to gastrointestinal issues or who require a more rapid increase in iron levels.
The Intravenous Iron market is highly competitive, with a number of companies offering products in this space. Some of the major players in the market include Vifor Pharma, Fresenius Kabi, American Regent, and B. Braun. Show Less Read more